These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 31222819

  • 1. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, Aoki S, Kuroda J, Ide M, Setoguchi K, Tsukamoto N, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Masaki Y.
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [Abstract] [Full Text] [Related]

  • 2. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
    Takai K.
    Biomedicines; 2024 Mar 14; 12(3):. PubMed ID: 38540266
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
    Iwaki N, Gion Y, Kondo E, Kawano M, Masunari T, Moro H, Nikkuni K, Takai K, Hagihara M, Hashimoto Y, Yokota K, Okamoto M, Nakao S, Yoshino T, Sato Y.
    Sci Rep; 2017 Feb 13; 7():42316. PubMed ID: 28205564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E, Rubenstein A, Pierson SK, Dalldorf D, Frank D, Lim MS, Fajgenbaum DC.
    Hematol Oncol; 2022 Apr 13; 40(2):191-201. PubMed ID: 35104370
    [Abstract] [Full Text] [Related]

  • 11. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N, Futatsuya C, Mizutani KI, Kumagai M, Shioya A, Guo X, Aikawa A, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Yamada S.
    Hum Pathol; 2018 Jul 13; 77():130-138. PubMed ID: 29684500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N, Mizutani KI, Kumagai M, Shioya A, Guo X, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Kida M, Yamada S.
    Pathol Res Pract; 2019 Mar 13; 215(3):410-413. PubMed ID: 30642741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome.
    Sumiyoshi R, Koga T, Kawakami A.
    Biomedicines; 2024 May 21; 12(6):. PubMed ID: 38927348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO.
    Phillips AD, Kakkis JJ, Tsao PY, Pierson SK, Fajgenbaum DC.
    J Cell Mol Med; 2022 Jun 21; 26(11):3147-3152. PubMed ID: 35488725
    [Abstract] [Full Text] [Related]

  • 18. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y, Ueda Y, Yanagisawa H, Arita K, Sakai T, Yamada K, Mizuta S, Fukushima T, Takai K, Aoki S, Kawabata H.
    Intern Med; 2023 Jan 01; 62(1):27-32. PubMed ID: 35598998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.